The effects of desferrioxamin and vitamin E as supplements to antibiotics in the treatment of peritonitis in rats

Journal of the Royal College of Surgeons of Edinburgh

Volumn 47, Issue 5, 2002, Pages 700-704

  Soybir, N ^a   Soybir, G ^b   Lice, H ^b   Dolay, K ^b   Ozseker A ^c   Koksoy F ^c  

^a MEMORIAL HOSPITAL   (Turkey)

^b Haseki State Hospital   (Turkey)

^c Taksim State Hospital   (Turkey)

Author keywords

Desferrioxamin; Peritonitis; Rat; Sepsis; Survival rates; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; DEFEROXAMINE MESYLATE; GENTAMICIN; IRON CHELATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CECUM; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; LIGATION; MALE; MORTALITY; NONHUMAN; PERITONITIS; PUNCTURE; RAT; SURVIVAL;

ANIMALS; CLINDAMYCIN; DEFEROXAMINE; DRUG THERAPY, COMBINATION; GENTAMICINS; MALE; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 0036814585     PISSN: 00358835     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zhang H, Slutsky AS, Vincent JL. Oxygen free radicals in ARDS, septic shock and organ dysfunction. Intensive Care Med 2000; 26(4): 474-476
2. Rotstein OD. Oxidants and antioxidant therapy. Crit Care Clin 2001; 17 (1): 239-247
3. Lehmann C, Egerer K, Georgiew A, Weber M, Grune T, Kox WJ. Inhibition of tumor necrosis factor-alpha release in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G. Crit Care Med 1999; 27(6): 1164-1167
4. Powell RJ, Machiýedo GW, Rush BF, Dikdtan GS. Effect of oxygen-free radical scavengers in survival in sepsis. Am Surg 1991; 57: 86-888
5. Fujimura N, Sumita S, Narimatsu E. Alteration in diaphragmatic contractility during septic peritonitis in rats: Effect of polyethylene glycol-absorbed superoxide dismutase. Crit Care Med 2000; 28(7): 2406-2414
6. Wang X, Quinn PJ. Vitamin E and its function in membranes. Prog Lipid Res 1999; 38(4): 309-336
7. Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol 1999; 37(9-10): 949-962
8. Farber JL. Mechanisms of cell injury by activated oxygen species. Environ Health Perspect 1994; 102(S 10): 17-24
9. Libra S, Pagano D, Curella G, Litrico V, Cancelliere M, Audibert D, La Terra S, Gruttadauria. S, Pappalardo A, D'Alessandro M. Experimental research on the use of deferoxamine in the prevention of renal damage from acute ischemia. Ann Ital Chir 1999; 70(4): 569-573
10. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock: a review of laboratory models and proposal. J Surg Res 1980; 29:189-201
11. Castillo M, Toledo-Pereyra LH, Gutierrez R, Prough D, Shapiro E. Peritonitis after cecal perforation. An experimental model to study the therapeutic role of antibiotics associated with allopurinol and catalase. Am Surg 1991; 57: 313-316
12. Halliwell B. Oxidants and human disease: Some new concepts. FASEB J 1987; 1(5): 358-364
13. Huffman LJ, Miles PR, Shi X, Bowman L. Hemoglobin potentiates the production of reactive oxygen species by alveolar macrophages. Exp Lung Res 2000; 26(3): 203-217
14. Kim YM. Counterprotective effect of erithrocytes in experimental bacterial peritonitis is due to scavenging of nitric oxide and reactive oxygen intermediates. Infect Immun 1996; 64(8): 3074-3080
15. Yoo YM, Kim KM, Kim SS, Han JA, Lea HZ, Kim YM. Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species. Clin Diagn Lab Immunol 1999; 6(6): 938-945
16. Halliwell B, Gutteridge JMC. Free radicals and human disease: the importance of free radicals and catalytic metal ions in human disease. Mol Aspect Med 1985; 8: 135-153
17. Bullen J, Griffiths E, Rogers H, Ward G. Sepsis: The critical role of iron. Microbes Infect 2000; 2 (4): 409-415
18. Simonart T, Degraef C, Andrei G, Mosselmans R, Hermans P, Van Vooren JP, Noel JC, Boelaert JR, Snoeck R, Heenen M. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. J Invest Dermatol 2000; 115(5): 893-900
19. Rakba N, Loyer P, Gilot D, Delcros JG, Glaise D, Baret P, Pierre JL, Brissot P, Lescoat G. Antiproliferative and apoptotic; effects of O-Trensox, a new synthetic iron chelator, on differentiated human hepatoma cell lines. Carcinogenesis 2000; 21(5): 943-951
20. Vlasov AP, Tarasova TV, Sudakova GI, Ashirov RS, Kil'diushov AN, Dubovskaia TN, Rubtsov OI, Lazareva OA. Effect of antioxidants on endotoxicosis in experimental peritonitis. Eksp Klin Farmakol 2000; 63(6): 58-61
21. Pekkanen T, Lindberg P, Sankari S. The effect of pre-treatment with vitamin E on the effects of endotoxin in the rat. Acta Pharmacol Toxicol 1983; 53: 64-69
22. Sugino K, Dohi K, Yamada K, Kaawasaki T. The role of lipid peroxidation in the endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 1987; 101: 746-752
23. Konukoǧlu D, Iynem H, Ziylan E. Antioxidant status in experimental periotonitis: Effects of alpha tocopherol and taurolin. Pharmacol Res 1999; 39(3): 247-251